Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander; Wouter van der Zwan; Jaap Teunissen; BLR Kam; R.A. Feelders; W.W. de Herder; Casper van Eijck; Gaston Franssen; Eric Krenning; Dik Kwekkeboom

doi:10.1158/1078-0432.ccr-16-2743

Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander
, Wouter van der Zwan
, Jaap Teunissen
, BLR Kam
, R.A. Feelders
, W.W. de Herder
, Casper van Eijck
, Gaston Franssen
, Eric Krenning
, Dik Kwekkeboom

Research output: Contribution to journal › Article › Academic › peer-review

571 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	4617-4624
Number of pages	8
Journal	Clinical Cancer Research
Volume	23
Issue number	16
DOIs	https://doi.org/10.1158/1078-0432.ccr-16-2743
Publication status	Published - 2017

Research programs

EMC MM-01-40-01

Access to Document

10.1158/1078-0432.ccr-16-2743

http://hdl.handle.net/1765/101556

Cite this

Brabander, T., van der Zwan, W., Teunissen, J., Kam, BLR., Feelders, R. A., de Herder, W. W., van Eijck, C., Franssen, G., Krenning, E., & Kwekkeboom, D. (2017). Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors. Clinical Cancer Research, 23(16), 4617-4624. https://doi.org/10.1158/1078-0432.ccr-16-2743

@article{fc7e994055cf4bf5bf3b12c70852c5b3,

title = "Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors",

author = "Tessa Brabander and \{van der Zwan\}, Wouter and Jaap Teunissen and BLR Kam and R.A. Feelders and \{de Herder\}, W.W. and \{van Eijck\}, Casper and Gaston Franssen and Eric Krenning and Dik Kwekkeboom",

year = "2017",

doi = "10.1158/1078-0432.ccr-16-2743",

language = "Undefined/Unknown",

volume = "23",

pages = "4617--4624",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "16",

}

Brabander, T, van der Zwan, W, Teunissen, J, Kam, BLR, Feelders, RA , de Herder, WW , van Eijck, C , Franssen, G, Krenning, E & Kwekkeboom, D 2017, 'Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors', Clinical Cancer Research, vol. 23, no. 16, pp. 4617-4624. https://doi.org/10.1158/1078-0432.ccr-16-2743

TY - JOUR

T1 - Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

AU - Brabander, Tessa

AU - van der Zwan, Wouter

AU - Teunissen, Jaap

AU - Kam, BLR

AU - Feelders, R.A.

AU - de Herder, W.W.

AU - van Eijck, Casper

AU - Franssen, Gaston

AU - Krenning, Eric

AU - Kwekkeboom, Dik

PY - 2017

Y1 - 2017

U2 - 10.1158/1078-0432.ccr-16-2743

DO - 10.1158/1078-0432.ccr-16-2743

M3 - Article

SN - 1078-0432

VL - 23

SP - 4617

EP - 4624

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 16

ER -